Skip to content
Clinical Trials – home
Research siteResponsive

Pneumologie Schlafmedizin und Onkologie am Diako Elke Dankelmann Bernhard Faderl Sabina Wehgartner-Winkler Michael Heller und Prof. Dr. med. Guenter Schlimok Partnerschaft

Germany Froelichstrasse 17, Innenstadt, 86150 Augsburg, Germany

  • 2 trials recruiting
  • Chronic obstructive pulmonary disease · Asthma
  • Adults and children

About Specializations

Pneumologie Schlafmedizin und Onkologie am Diako Elke Dankelmann Bernhard Faderl Sabina Wehgartner-Winkler Michael Heller und Prof. Dr. med. Guenter Schlimok Partnerschaft in Augsburg, Germany specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The center at the Zentrum für Pneumologie, Onkologie und Schlafmedizin am Diako conducts focused research on severe eosinophilic asthma, a challenging form of respiratory disease.

  • Evaluation of innovative anti‑eosinophilic treatments
  • Long‑term safety and tolerability assessment
  • Reduction of asthma exacerbation rates

Ongoing trials are designed to demonstrate the efficacy of a new therapy in lowering severe asthma attacks and enhancing patient wellbeing, reflecting the site’s commitment to advancing respiratory care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Froelichstrasse 17, Innenstadt86150 AugsburgGermany
Recruiting now
2 trials
Conditions studied
2

More sites in AugsburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.